With pages of accolades, we welcomed as our guest speaker Ms. Yinka Oshodi of CBCC, Comprehensive Blood and Cancer Center (CBCC). Yinka serves as Senior Clinical Research Manager. Now before some of you get this vision of Dr. Frankenstein, Yinka is anything but that. Yes, her role is to oversee the good progress of the medical researchers that are trying new concoctions to starve off cancer cells, her department’s work presents viable options to patients to overcome the grips of the disease. 
 
Honestly, I had no idea that in Bakersfield, CBCC is performing research upon living participants to cure disease. Yinka gave us the particulars of what the process of validating potential cures for disease look like. For instance, before the FDA can approve medical procedures upon people, there is a process which involves small group tests. If early signs are promising of patient improvement, a larger group is invited to partake in the voluntary research. Comparisons of treatment plans are made with similar processes (drugs) and even comparison to processes in other countries. At the end of such research studies, data is sent to the FDA for approval. Yinka said that it takes between 5 to 15 years from the time research begins until final approval is made to publically administer a treatment of a drug.
 
Interestingly, I noticed an article in today’s news that President Trump is leaning to signing a bill allowing the entry into the USA of medical treatments from Canada. I hope this and other miraculous work from CBCC, Yinka and research teams like them help the sick very soon. Great work CBCC and Yinka!
 
Did you know that at our CBCC there are 19 active clinical trials of various medical treatments!